ovarian function suppression/ablation
Showing 1 - 25 of >10,000
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian
Not yet recruiting
- Hormone-receptor-positive Breast Cancer
- +3 more
- Aromatase inhibitor
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with
Not yet recruiting
- Breast Cancer
- +4 more
- Ovarian function suppression with endocrine treatments
-
Seoul, Korea, Korea, Republic ofGangnam Severance Hospital
Dec 18, 2022
Breast Cancer Survivors, Sexual Function Disturbances, Ovarian Suppression Treatment Trial in Boston (Group Session, Telephone
Completed
- Breast Cancer Survivors
- +2 more
- Group Session
- Telephone Booster
-
Boston, MassachusettsDana Farber Cancer Institute
Nov 11, 2021
Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)
Recruiting
- Breast Cancer Invasive
- Leuplin or zoladex
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 16, 2022
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Cognitive Impairment, Estrogen Deficiency, Menopause Trial in Aurora, Boulder (GnRHant + E2, GnRHant + Placebo)
Completed
- Cognitive Impairment
- +4 more
- GnRHant + E2
- GnRHant + Placebo
-
Aurora, Colorado
- +1 more
Jun 3, 2021
Breast Cancer Trial in Shanghai (OFS + Anastrozole, OFS + Exemestane)
Completed
- Breast Cancer
- OFS + Anastrozole
- OFS + Exemestane
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022
RWE About QOL and Compliance of Patients With OFS in China
Not yet recruiting
- Breast Cancer
- +2 more
- 3M GnRHa
- 1M GnRHa
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 15, 2021
Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Johannesburg, South AfricaWits Oncology center
Jul 22, 2021
Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- +7 more
- Exemestane
- +6 more
-
Birmingham, Alabama
- +499 more
Nov 15, 2022
Breast Cancer Trial (SHR-1316 at a dose 20mg/kg q3w, SHR6390 at a dose of 150mg orally, daily, SBRT)
Recruiting
- Breast Cancer
- SHR-1316 at a dose 20mg/kg q3w
- +2 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Sep 12, 2022
Premature Ventricular Contractions, Ventricular Dysfunction, Left Trial (Experimental group, Control group)
Not yet recruiting
- Premature Ventricular Contractions
- Ventricular Dysfunction, Left
- Experimental group
- Control group
- (no location specified)
Mar 27, 2023
Improve Sexual Health, Improve Vulvovaginal Health Trial in United States (questionnaires, moisturizers)
Recruiting
- Improve Sexual Health
- Improve Vulvovaginal Health
- questionnaires
- moisturizers
-
Basking Ridge, New Jersey
- +6 more
Jun 9, 2023
CYP2D6 Polymorphism Trial in Beijing (drug, other, genetic)
Enrolling by invitation
- CYP2D6 Polymorphism
- Exemestane Tablets
- +3 more
-
Beijing, Beijing, ChinaCancerIHCAMS
Oct 28, 2018
CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective
Recruiting
- Breast Cancer
- +2 more
-
Erlangen, GermanyDepartment of Gynecology and Obstetrics, Erlangen University Hos
May 12, 2023
Breast Cancer Trial in Guangzhou (Tucidinostat, Exemestane, Ovarian function suppression)
Unknown status
- Breast Cancer
- Tucidinostat
- +2 more
-
Guangzhou, Guangdong, ChinaThe first affiliated hospital of Sun Yat-Sen university
Jul 22, 2020
Metastatic Breast Cancer, Breast Cancer Stage IV Trial in São Paulo
Recruiting
- Metastatic Breast Cancer
- Breast Cancer Stage IV
-
São Paulo, SP, BrazilHcor
Sep 26, 2022
Contraception Trial in Salt Lake City (ENG implant, oral ulipristal acetate)
Active, not recruiting
- Contraception
- ENG implant
- oral ulipristal acetate
-
Salt Lake City, UtahUniversity of Utah
Nov 1, 2022
Premature Ovarian Failure Trial in Ulaanbaatar (stem cell therapy)
Not yet recruiting
- Premature Ovarian Failure
- stem cell therapy
-
Ulaanbaatar, MongoliaMongolian National University of Medical Science
Nov 13, 2023
Diminished Ovarian Reserve Trial ("KB-120" small molecular nutrient and vitamin E, Vitamin E)
Not yet recruiting
- Diminished Ovarian Reserve
- "KB-120" small molecular nutrient and vitamin E
- Vitamin E
- (no location specified)
Oct 15, 2023
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Tampa (Aspirin 325mg, Placebo)
Suspended
- Ovarian Cancer
- +2 more
- Aspirin 325mg
- Placebo
-
Tampa, FloridaMoffitt Cancer Center
Oct 12, 2022
Tumors Prostate, Cancer of the Prostate Trial in Miami Lakes (Image Fusion (MR/US) Software Registration Guided Laser Ablation
Recruiting
- Neoplasms Prostate
- Cancer of the Prostate
- Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer
-
Miami Lakes, FloridaUrological Research Network
Feb 2, 2022
Ventricular Tachycardia (VT) Trial in Canada, France, United States (Antiarrythmic Drug Therapy, Catheter ablation)
Active, not recruiting
- Ventricular Tachycardia (VT)
- Antiarrythmic Drug Therapy
- Catheter ablation
-
Nashville, Tennessee
- +20 more
Jun 20, 2022